Position in ABT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,730,194
+$433,120 QoQ
Shares Held
16,852
+74.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026FOX RUN MANAGEMENT, L.L.C. holds $13,348,647 across 17 Medical Devices names. ABT ranks #2 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
8,309 | $1,743,560 | |
| 2 | ABT |
Abbott Laboratories
This page
|
16,852 | $1,730,194 | |
| 3 | EW |
Edwards Lifesciences Corp
|
16,166 | $1,294,573 | |
| 4 | DXCM |
Dexcom Inc
|
17,443 | $1,095,420 | |
| 5 | BSX |
Boston Scientific Corp
|
16,055 | $1,007,451 | |
| 6 | SYK |
Stryker Corp
|
2,888 | $948,967 | |
| 7 | ITGR |
Integer Holdings Corp
|
9,620 | $846,560 | |
| 8 | CNMD |
CONMED Corp
|
19,776 | $699,279 |
All Filings in ABT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,730,194 | 16,852 | Shares | Sole | 2026-05-12 | |
| 2025-09-30 | $1,297,074 | 9,684 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $1,523,112 | 14,658 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $403,076 | 3,662 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $815,767 | 8,423 | Shares | Sole | 2023-11-07 | |
| 2022-03-31 | $658,318 | 5,562 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $526,508 | 3,741 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $428,575 | 3,628 | Shares | Sole | 2021-11-15 | |
| 2020-06-30 | $397,903 | 4,352 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||